Keya Medical
PrivateLast Round
Series D
Extension
Jul 22, 2021
Est. Valuation
$898.3M
Total Funding Raised
$251M
Company Overview
Keya Medical operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series D Extension round in July 2021.
Keya Medical is a medical technology company that develops and provides artificial intelligence-based software and devices for disease diagnosis and treatment, specializing in deep learning solutions for cardiology, neurology, and pulmonology.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Medical Devices
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Keya Medical Comparables
Compare Keya Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aidoc | 87% | |
| Viz.ai | 83% | |
| Qure.ai | 82% |
For institutional investors. Book with your work email.
Keya Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Jul 22, 2021 | ||||
| Series D | Jan 14, 2021 | ||||
| Series C | Nov 12, 2020 | ||||
| Series B Extension | Aug 13, 2020 | ||||
| Strategic | Feb 1, 2020 | ||||
Series C Extension | Dec 7, 2018 |
For institutional investors. Book with your work email.
Keya Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alwin Capital | Strategic, Series B Extension, Series C |
| IDG Capital | Strategic, Series C |
| INcapital Ventures | Series D |
| CCIC Capital | Series D |
| Taihe Capital | Series C Extension |
| Tasly Holding Group | Series C |
| Yueyin Medical Fund | Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 20, 2025
Will be exhibiting at the RSNA 2025 conference.
- Jul 8, 2025
Expanding US offices to increase regional coverage.
For institutional investors. Book with your work email.
Keya Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Keya Medical's valuation, stock price, and market status.
Is Keya Medical a public or private company?
Keya Medical is a private company.
What is the current stock price of Keya Medical?
Keya Medical is a private company, so its shares have no public market price. Caplight tracks Keya Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Keya Medical worth (valuation)?
Keya Medical's valuation is estimated at $898.3M based on funding round data.
Can I buy Keya Medical stock?
Keya Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Keya Medical's last funding round?
Keya Medical's most recent funding round was Series D Extension on July 22, 2021.
Who are the main investors in Keya Medical?
Key investors in Keya Medical include IDG Capital, Goldman Sachs Asset Management Private Equity, GGV Capital, CDH Investments.
Will Keya Medical IPO soon?
No public IPO plans have been announced for Keya Medical.
How can I track Keya Medical secondary market activity?
Caplight tracks bids, offers, and trades in Keya Medical's shares on secondary markets.